The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
As of today (2026-07-12), Elevance Health's 5-Day RSI is 59.36.
The industry rank for Elevance Health's 5-Day RSI or its related term are showing as below:
ELV's 5-Day RSI is ranked worse than 66.67% of 18
companies
in the Healthcare Plans industry
Industry Median: 53.515
vs ELV: 59.36
Elevance Health (NYSE:ELV) 5-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Elevance Health 5-Day RSI Related Terms
ELV vs CI, HUM, CVS: 5-Day RSI Comparison
For the Healthcare Plans subindustry, Elevance Health's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elevance Health 5-Day RSI vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Elevance Health's 5-Day RSI distribution charts can be found below:
* The bar in red indicates where Elevance Health's 5-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health (ELV) has a 5-Day RSI of 59.36 as of Jul. 12, 2026. According to the industry distribution chart, Elevance Health ranks #12 out of 18 companies in the Healthcare Plans industry, placing it in the top 66.7%.
Is Elevance Health's 5-Day RSI too high?
Elevance Health's current 5-Day RSI is 59.36. The Healthcare Plans industry median 5-Day RSI is 53.52. Elevance Health's value of 59.36 is 10.9% above this industry median. Based on the distribution chart, Elevance Health ranks #12 out of 18 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Elevance Health has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's 5-Day RSI compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #12 out of 18 companies for 5-Day RSI. This places Elevance Health in the lower half of its industry. The industry median 5-Day RSI is 53.52. Elevance Health's value of 59.36 is 10.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Healthcare Plans company?
The median 5-Day RSI among Healthcare Plans companies is 53.52, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Elevance Health's current 5-Day RSI of 59.36 is 10.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Plans industry, the median 5-Day RSI is 53.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current 5-Day RSI is 59.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is $507.80, compared to a current price of $416.23 — trading 18% below its estimated fair value. The current 5-Day RSI is 59.36 and 10.9% above the Healthcare Plans industry median of 53.52. Elevance Health's overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For Elevance Health (ELV), the current 5-Day RSI is 59.36 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Elevance Health (ELV) Overvalued in 2026?
Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued.
The current stock price of $416.23 is trading 18% below its estimated GF Value™ of $507.80.
GuruFocus considers Elevance Health to be Modestly Undervalued.
Key valuation signals for ELV:
5-Day RSI: 59.36
GF Value™: $507.80 vs. price of $416.23 (18% below fair value)
Industry Position: 10.9% above the Healthcare Plans median (#12 of 18)
No single metric tells the full story. See the ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
88GF Score
Get the complete analysis for ELV
5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ELV has been successfully added to your 